ARCHIVES

CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions

This article is from The Cancer Letter archive.

Vol. 09 No. 18 | May 6, 1983

Download PDF Visit The Full Archive

Related Articles

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

Study Section Members Likelier to Be Funded

August 1, 1986

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985